Biotech · Public company · San Diego, CA, US

Janux Therapeutics, Inc.

Ticker JANX · SEC CIK 0001817713

Track this companyFree. Adds Janux Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials44 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline5

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPCPHASE1 · RECRUITING · started Sep 10, 2026ClinicalTrials.gov NCT07813637 · fetched Nov 12, 2026
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate CancerPHASE1 · RECRUITING · started Apr 15, 2026ClinicalTrials.gov NCT07545811 · fetched Nov 12, 2026
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 19, 2023ClinicalTrials.gov NCT05783622 · fetched Nov 12, 2026
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)PHASE1 · RECRUITING · started Sep 15, 2022ClinicalTrials.gov NCT05519449 · fetched Nov 12, 2026